The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vatsal Pandya
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vatsal Pandya, a non-promoter acquirer, has acquired 2,50,000 equity shares (1.34%) of Integrated Proteins Limited through a preferential allotment on August 7, 2025. Before this acquisition, he held no direct shares but held 2,50,000 warrants, which have now been converted into equity shares. The company's total share capital expanded sharply from 32,03,600 shares (Rs. 3.2 crore) to 1,87,13,600 shares (Rs. 18.7 crore) as part of this preferential issue. This is a regulatory disclosure under SEBI's takeover regulations regarding a small acquisition.
This is a minor, non-promoter acquisition via preferential allotment and is unlikely to materially affect existing shareholders. The significant expansion of share capital through the preferential issue may lead to dilution for existing shareholders.